What is Bowman and Brooke?
Bowman and Brooke LLP operates as a sophisticated national product liability defense firm, deploying a robust network of over 200 attorneys across 17 strategic offices. The firm distinguishes itself through deep expertise in high-profile product liability litigation, serving a diverse portfolio of corporate clients spanning the motor vehicle, pharmaceutical, medical device, and industrial equipment sectors. By integrating specialized knowledge in class action, multidistrict litigation, and toxic tort defense, the firm provides comprehensive legal counsel that addresses the multifaceted challenges inherent in modern corporate liability. Their reputation is built upon a foundation of trial excellence and a commitment to diversity, positioning them as a critical partner for enterprises facing complex, multi-jurisdictional legal threats.
How much funding has Bowman and Brooke raised?
Bowman and Brooke has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in Bowman and Brooke
PPP
Public-Private Partnership
What's next for Bowman and Brooke?
With the recent capital deployment, Bowman and Brooke is well-positioned to scale its litigation support infrastructure and enhance its technological capabilities in case management. As the firm moves forward, the focus will likely shift toward expanding its footprint in emerging areas of environmental and toxic tort litigation, where regulatory scrutiny is intensifying. By leveraging this major enterprise-level funding, the firm aims to bolster its trial prowess and continue its trajectory of growth, ensuring that it remains at the forefront of the defense sector. The strategic allocation of these resources will facilitate the recruitment of top-tier legal talent and the refinement of proprietary defense methodologies, ultimately driving long-term value for their corporate clientele.
See full Bowman and Brooke company page
